Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.55 |
| ▸ | TP53 | P04637 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | CCR1 | P32246 | 3/20 | 0.55 |
| ▸ | CCR5 | P51681 | 3/20 | 0.55 |
| ▸ | CCR8 | P51685 | 3/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | ALPL | P05186 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | ALPG | P10696 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 6/20 | 0.53 |
| ▸ | RAB9A | P51151 | 6/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12425309 | 0.89 | KDM4E (0.69) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL2197485 | 0.83 | SMN1; SMN2 (0.60) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL2554742 | 0.83 | KDM4E (0.60) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL29244073 | 0.81 | SMN1; SMN2 (0.58) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL367895 | 0.80 | SMN1; SMN2 (0.56) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL29398228 | 0.80 | SMN1; SMN2 (0.56) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL29756481 | 0.80 | SMN1; SMN2 (0.56) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL2202802 | 0.80 | SMN1; SMN2 (0.56) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL2198833 | 0.78 | SMN1; SMN2 (0.53) | KDM4ETP53SMN1; SMN2LMNACCR1 | |
| SCHEMBL17320277 | 0.78 | SMN1; SMN2 (0.53) | KDM4ETP53SMN1; SMN2LMNACCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385052-B1 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO LTD (JP) | 2013-11-13 | — | — | EP | disclosed |
| EP-2385052-B1 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO LTD (JP) | 2013-11-13 | — | — | EP | disclosed |
| EP-2385052-A1 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | Hodogaya Chemical Co., Ltd. (JP) | 2011-11-09 | — | — | EP | disclosed |
| US-7977671-B2 | Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977671-B2 | Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977671-B2 | Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7812341-B2 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-7812341-B2 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-7812341-B2 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100066244-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100066244-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100066244-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20080017846-A1 | Compound Having Oxadiazole Ring Structure Substituted with Pyridyl Group, and Organic Electroluminescent Device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2008-01-24 | — | — | US | disclosed |
| US-20080017846-A1 | Compound Having Oxadiazole Ring Structure Substituted with Pyridyl Group, and Organic Electroluminescent Device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2008-01-24 | — | — | US | disclosed |
| US-20080017846-A1 | Compound Having Oxadiazole Ring Structure Substituted with Pyridyl Group, and Organic Electroluminescent Device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2008-01-24 | — | — | US | disclosed |
| EP-1746094-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746094-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2007-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100066244-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE | OXA1L, LEF1, PNPO | KDM4E 608/4885TP53 4312/4885SMN1; SMN2 3259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.